NCT02633982View on ClinicalTrials.gov

GENERAL;GENeral Practitioners and Embolism pRevention in NVAF Patients Treated With RivAroxaban:reaL-life Evidence

UnknownOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Atrial Fibrillation
Trial Locations (1)

565-8565

RECRUITING

Japan Cardiovascular Research Foundation, Suita

Sponsors
All Listed Sponsors
lead

Japan Cardiovascular Research Foundation

OTHER